Metabolic and cardiovascular effects of carvedilol and atenolol in non- insulin-dependent diabetes mellitus and hypertension: A randomized, controlled trial

Annals of Internal Medicine

Volumn 126, Issue 12, 1997, Pages 955-959

  Giugliano, Dario ^a,b   Acampora, Rita ^a,c   Marfella, Raffaele ^a   De Rosa, Nicoletta ^a   Ziccardi, Patrizia ^a   Ragone, Raffaele ^a   De Angelis, Lorenita ^a,c   D'Onofrio, Felice ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Second University of Naples ^*  (Italy)

^c Centro Antidiabete Lepanto   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; CARVEDILOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; INSULIN RESPONSE; INSULIN SENSITIVITY; LIPID PEROXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030943599     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-12-199706150-00004     Document Type: Article

References (20)

1. Sowers JR, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update. Hypertension. 1995;26(6 pt 1): 869-79.
2. Lithell HO. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care. 1991;14:203-9.
3. Malmberg K, Herlitz J, Hjalmarson A, Ryden L. Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies. Eur Heart J. 1989;10: 423-8.
4. McTavish D, Campoli-Richards D, Sorkin EM. Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs. 1993;45:232-58.
5. Tomlinson B, Bompart F, Graham BR, Liu JB, Prichard BN. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine. Drugs. 1988; 36(Suppl 6):37-47.
6. Feuerstein GZ, Ruffolo RR Jr. Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection. Eur Heart J. 1995;16(Suppl F):38-42.
7. Giugliano D, Ceriello A, Paolisso G. Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism. 1995;44: 363-8
8. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance Am J Physiol. 1979;237:E214-23.
9. Giugliano D, De Rosa N, Marfella R, Di Maro G, Cacciapuoti F, Quatraro A, et al. Comparison of nitrendipine and cilazapril in patients with hypertension and non-insulin-dependent diabetes mellitus. Am J Hypertens. 1993;6:927-32.
10. Paolisso G, Giugliano D, Scheen AJ, Franchimont P, D'Onofrio F, Lefebvre PJ. Primary role of glucagon release in the effect of beta-endorphin on glucose homeostasis in normal man. Acta Endocrinol (Copenh). 1987;115: 161-9
11. Waravdekar VS, Sadlaw LD. A sensitive chlorometric method for the estimation of 2-deoxysugars with the use of the malondialdehyde thiobarbituric reaction. J Biol Chem. 1950;234:1945-50.
12. Allison DB, Paultre F, Maggio C, Mezzitis N. Pi-Sunyer FX. The use of areas under curves in diabetes research Diabetes Care. 1995;18:245-50.
13. Smith RS, Warren DJ. Effects of acute oral beta adrenergic blockade on muscle blood flow in man. Cardiovasc Res. 1982;16:205-8.
14. Lind L, Lithell H. Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia. Am Heart J. 1993;125:1494-7.
15. Pollare T, Lithell H, Selinus I, Berne C. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. BMJ. 1989;248:1152-7.
16. Lager I, Blohme G, Smith U. Effects of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin dependent diabetes. Lancet. 1979;1:458-62.
17. Herings RM, de Boer A, Striker BH, Leufkens HG, Porsius A. Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme. Lancet. 1995;345:1195-8.
18. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996;19:257-67.
19. Alexander RW. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension. 1995;25: 155-61.
20. Jonas M, Reicher-Reiss H, Boyko V, Shotan A, Mandelzweig L, Goldbourt U, et al. Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary heart disease. Bezafibrate Infarction Prevention (BIP) Study Group. Am J Cardiol. 1996;77:1273-7.